Helping older patients with kidney disease make treatment decisions
Official title: Improving Kidney Therapy Decision-Making for Older People With Advanced Chronic Kidney Disease (CKD)
Run by University of Rochester · NCT06410144 · Data updated 2026-11-12
This study is testing which type of support helps older patients with kidney disease make better treatment choices, either through a kidney educator or a decision-support specialist.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 75 Years and up |
| Sex | All |
| Enrollment | 326 (estimated) |
| Sponsor | University of Rochester Academic / other |
| Locations | 5 sites (Brockport, New York and 4 other locations) |
| Status | Recruiting |
| Started | February 27, 2025 |
| Main results expected | June 30, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | May 5, 2026 |
| Trial ID | NCT06410144 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are older adults aged 75 and above with advanced kidney disease and a kidney function of less than 30% who have not yet made a dialysis decision.
✕Probably not a fit
Patients who have already decided on dialysis or are currently on dialysis will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to determine which educational program better assists older patients with chronic kidney disease in making informed treatment choices. Participants aged 75 and older will be divided into two groups, with one receiving information from the National Kidney Foundation and meetings with a kidney therapy educator, while the other will receive guidance from a decision-support specialist. The study will evaluate the effectiveness of these programs in reducing hospital visits and improving end-of-life care over a six-month period. The goal is to enhance the decision-making process for patients facing dialysis options.
Why it matters
Potential benefit: If successful, this study could empower older patients with chronic kidney disease to make better-informed treatment decisions and improve their overall quality of life.
How similar studies have gone: This approach is novel as it integrates palliative care into nephrology, focusing on decision-making for older patients with advanced chronic kidney disease.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 75 years old * Has advanced kidney disease with kidney function less than 30% * Speaks English * Has not yet made a dialysis decision Exclusion Criteria: * Has already decided on dialysis or active medical care without dialysis. * Has already been seen by a Palliative Care (PC) clinician for kidney-related issues or is enrolled in hospice * Currently on dialysis * Unable to provide informed consent or complete verbally administered surveys due to health, sensory, or cognitive impairment.
Where it's running
-
UR Medicine Nephrology - Strong West
Brockport, New York, United States Recruiting -
Nephrology Clinic - Thompson Professional Building
Canandaigua, New York, United States Recruiting -
Nephrology Clinic - St. James Medical Office Building
Hornell, New York, United States Recruiting -
Highland Hospital
Rochester, New York, United States Recruiting -
University of Rochester Medical Center
Rochester, New York, United States Recruiting
Study contacts
- Principal investigator: Fahad Saeed, MBBS, MSCI — University of Rochester
- Study coordinator: Brooke Study Coordinator
- Email: KidneyEducation@urmc.rochester.edu
- Phone: 585-275-7033
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes
This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.
-
Impact of TAVR on kidney function in people with aortic valve disease
This registry tests how trans-catheter aortic valve implantation affects kidney function and the risk of kidney injury in adults with aortic stenosis.
-
Calciphylaxis in people with chronic kidney disease: causes, risks, and early signs
This project will compare adults with chronic kidney disease who develop calciphylaxis to matched CKD patients who do not, collecting clinical data and biological samples to try to find risk factors and early signs.
-
Oral Semaglutide for CKD and MAFLD in adults with diabetes
This study tests whether adding oral semaglutide to standard care can slow kidney and liver disease progression in adults with CKD and MAFLD who have type 2 diabetes.
-
Eye-brain-kidney connections in chronic kidney disease
This study will see if changes in brain network connectivity and retinal blood vessels are linked to cognitive decline and kidney function in adults with chronic kidney disease.
-
Screening for chronic kidney disease
We will see how common chronic kidney disease is among adults followed at a tertiary care center and how many cases were previously undiagnosed.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.